Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
about
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.Estimating the direct and indirect costs associated with Parkinson's disease.Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.Average annual cost of Parkinson's disease in São Paulo, Brazil, with a focus on disease-related motor symptoms.Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort studyIron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications
P2860
Q36254618-93C43215-4AEA-4F01-AB50-AF6A50969281Q38080952-EBE2217C-C539-422A-8F49-7D5E2C9BC520Q38109630-F00097B3-F3D4-4C83-B766-6B1C21337073Q38618871-A85E36B4-DD61-42DC-B18F-6671F5808C30Q40422920-74B25DCD-891C-4ADF-A261-F7C04A1DA0F0Q47098412-70E149FA-75A8-443A-9620-E1348092280CQ58609462-0E0766E2-B82C-48B7-AAB1-FE10EB16BAB8Q58754278-3E62B26F-8A3E-4017-8ACA-556F880E1BBC
P2860
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@en
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@nl
type
label
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@en
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@nl
prefLabel
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@en
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@nl
P2093
P2860
P1476
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease.
@en
P2093
Jens P Reese
Judith Dams
Monika Balzer-Geldsetzer
Richard Dodel
Yaroslav Winter
P2860
P304
P356
10.1517/14656566.2012.677435
P407
P577
2012-04-05T00:00:00Z